FDAnews Announces FDA Digital Health Regulation: Latest Developments for Medical Device Manufacturers Webinar April 8, 2021 prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
FDAnews Announces Artificial Intelligence and Machine Learning in Medical Technology: Fundamentals and Emerging Regulations Webinar Sponsored by ComplianceQuest March 18
Share Article
WCG FDANews Artificial Intelligence and Machine Learning in Medical Technology:
Fundamentals and Emerging Regulations
Thursday, March 18, 2021, 11:00 a.m.-12:00 p.m. EDT
Artificial intelligence (AI) and machine learning (ML) will be among the top innovations in medical technology this decade. Get ready to join the revolution.
Don’t be left behind this free webinar explains what one must know about the fundamentals and emerging regulations.
While the possibilities are vast, AI and ML are accompanied by many issues and challenges for manufacturers, clinicians/technicians, engineers, quality assurance, regulatory affairs, clinical professionals and regulators.
FDAnews Announces Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19 Webinar March 18, 2021
Share Article
Is the pandemic making postmarket surveillance even more difficult? Two former FDAers explain how to comply. Register today.
WCG FDAnews Pharmaceutical Postmarket Surveillance:
An FDAnews Webinar
Are you confident you’re compliant with current FDA postmarket adverse event reporting regulations? Postmarket surveillance can be difficult during the best of times. And in the COVID-19 era it’s become even more difficult.
Cynthia Schnedar, Executive Vice President of Regulatory Compliance at Greenleaf Health and former Director of the Office of Compliance for FDA’s Center for Drug Evaluation and Research (CDER) and Dawn Wynder, a Project Manager for FDAQRC and a former FDA Investigator, will ensure attendees understand how the FDA conducts its postmarket safety surveillance and what one must do to ensure postmarket adverse reporting inspe
FDAnews Announces Pharmaceutical Naming Regulation: Understanding the Latest Developments Webinar March 16, 2021
Share Article
Will a proposed drug name stand up to FDA scrutiny? Drug-naming expert explains what one must know. Register today.
WCG FDAnews Pharmaceutical Naming Regulation:
Will a proposed drug name stand up to FDA scrutiny?
The FDA’s recently released naming guidance has several key additions and changes one must understand when developing names. Failure to follow the guidelines could create confusion and lead to medication errors.
Susan M. Proulx, PharmD, Managing Director, Drug Safety at Leaderboard Branding is an international leader in preventing medication errors due to brand name confusion. During this webinar she’ll share:
FDAnews Announces FDA Drug GMP Facility Inspections During the Pandemic Webinar March 10, 2021
PRWeb
FacebookTwitterEmail
FALLS CHURCH, Va. (PRWEB) February 24, 2021
FDA Drug GMP Facility Inspections During the Pandemic
An FDAnews Webinar
Has one’s inspection timeline been thrown for a loop because of COVID-19? How exactly will sites move forward with the FDA?
The FDA restarted inspections last summer under a new guidance and during this webinar FDA inspections expert Kalah Auchincloss will share how assessments are proceeding and what criteria the FDA is using to determine which sites are inspected. Through Auchincloss’ experienced perspective, gain insights into how to prepare for an on-site inspection, from extended records requests to appropriate personnel access. We’ll also consider how the FDA is deciding on remote inspections and ways to equip your team for this method of assessment.